Initiation of phase I study evaluating MB-101 in patients with leptomeningeal brain tumors Dec. 22, 2020
CTA approved in Belgium for phase l/lla study of oncolytic virus BT-001 in solid tumors Dec. 22, 2020
Singapore HSA approves CANbridge's IND for CAN-106 for complement dysregulation diseases Dec. 22, 2020